The Dual Role of Nanoparticle Agents in Multimodal Imaging and Treatment of Gliomas
Sydney Zhou Introduction. Glioblastoma multiforme (GBM) has a median survival of 9-12 months and is a challenging cancer to diagnose and treat.1 Prognosis is significantly improved with >98% extent of resection (EOR).2 However, limitations of imaging modalities such as magnetic resonance (MR) imaging and computed tomography (CT) hinder the differentiation…